EU

Eugen Uhlmann

Hoechst Gmbh: 31 patents #54 of 4,020Top 2%
AG Aventis Pharma Deutschland Gmbh: 11 patents #23 of 418Top 6%
CG Coley Pharmaceutical Gmbh: 11 patents #5 of 63Top 8%
SA Sanofi-Aventis: 7 patents #197 of 1,008Top 20%
TM Translate Bio Ma: 6 patents #3 of 14Top 25%
IG Isarna Therapeutics Gmbh: 5 patents #2 of 6Top 35%
Pfizer: 2 patents #2,078 of 5,153Top 45%
The General Hospital: 2 patents #806 of 3,021Top 30%
HA Hoescht Aktiengesellschaft: 1 patents #26 of 159Top 20%
AS Aventis Pharma S.A.: 1 patents #304 of 591Top 55%
CN CNRS: 1 patents #3,857 of 11,908Top 35%
📍 Königstein, MA: #1 of 2 inventorsTop 50%
Overall (All Time): #22,762 of 4,157,543Top 1%
80
Patents All Time

Issued Patents All Time

Showing 1–25 of 80 patents

Patent #TitleCo-InventorsDate
10844375 Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers Romesh R. Subramanian, Arthur M. Krieg 2020-11-24
10704046 Multimeric oligonucleotide compounds Markus Weber, Romesh R. Subramanian, Thomas Rockel, Arthur M. Krieg 2020-07-07
10538768 Modified TGF-beta oligonucleotides Frank JASCHINSKI, Michel Janicot 2020-01-21
10260071 CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity Harald Debelak, Marion Jurk 2019-04-16
10125368 Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease Frank JASCHINSKI, Michel Janicot, Eugen Leo 2018-11-13
10093924 Multimetric oligonucleotide compounds Markus Weber, Romesh R. Subramanian, Thomas Rockel, Arthur M. Krieg 2018-10-09
9926563 Modified TGF-beta oligonucleotides Frank JASCHINSKI, Michel Janicot 2018-03-27
9840707 Modified TGF-beta2 oligonucleotides Frank JASCHINSKI, Michel Janicot 2017-12-12
9790494 Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers Romesh R. Subramanian, Arthur M. Krieg 2017-10-17
9732341 Methods of delivering multiple targeting oligonucleotides to a cell using cleavable linkers Markus Weber, Romesh R. Subramanian, Thomas Rockel, Arthur M. Krieg 2017-08-15
9732340 Multimeric oligonucleotides compounds having cleavable linkers Markus Weber, Romesh R. Subramanian, Thomas Rockel, Arthur M. Krieg 2017-08-15
9688988 Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease Frank JASCHINSKI, Michel Janicot, Eugen Leo 2017-06-27
9580708 Multimeric oligonucleotides compounds Markus Weber, Romesh R. Subramanian, Thomas Rockel, Arthur M. Krieg 2017-02-28
9382545 CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity Harald Debelak, Marion Jurk 2016-07-05
9200287 Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity Marion Jurk 2015-12-01
9186399 Immune stimulatory oligonucleotide analogs containing modified sugar moieties Harald Debelak, Marion Jurk, Markus Weber 2015-11-17
9156875 Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties Harald Debelak 2015-10-13
8772469 Synthetic double-stranded oligonucleotides for specific inhibition of gene expression Jochen Huber, Niki Gunkel, Sandra Neumann 2014-07-08
8580268 CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity Harald Debelak, Marion Jurk 2013-11-12
8349812 Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties Harald Debelak 2013-01-08
8304396 Immunostimulatory nucleic acids Arthur M. Krieg, Ulrike Samulowitz, Jorg Vollmer, Marion Jurk, Grayson B. Lipford +1 more 2012-11-06
8283328 Immunostimulatory nucleic acids Arthur M. Krieg, Grayson B. Lipford, Ulrike Samulowitz, Jorg Vollmer, Marion Jurk +1 more 2012-10-09
8268560 Polymide nucleic acid derivatives, and agents and processes for preparing them Gerhard Breipohl, David William Will 2012-09-18
8198251 Combination motif immune stimulatory oligonucleotides with improved activity Jorg Vollmer, Arthur M. Krieg, Douglas Charles Hanson, Ulrike Samulowitz 2012-06-12
8188254 C-class oligonucleotide analogs with enhanced immunostimulatory potency Jorg Vollmer, Arthur M. Krieg, Bernhard Noll 2012-05-29